azacitidine and oligonucleotides

azacitidine has been researched along with oligonucleotides in 12 studies

Research

Studies (12)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (16.67)	18.7374
1990's	2 (16.67)	18.2507
2000's	3 (25.00)	29.6817
2010's	5 (41.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Muthuchamy, M; Pajak, L; Wieczorek, DF	1
Bianchi, MS; Bianchi, NO; Larramendy, M	1
Strobl, JS; Thompson, EB	1
Bhagwat, AS; Gabbara, S	1
Draghici, S; Kraniak, JM; Kulaeva, OI; Land, SJ; Tainsky, MA; Tang, L	1
Egger, G; Jeong, S; Jones, PA; Liang, G; Phiasivongsa, P; Redkar, S; Tang, C; Yoo, CB	1
Drew, PA; Jones, ME; Smith, E	1
Li, HL; Ma, AN	1
Bearss, DJ; Chuang, JC; Jones, PA; Qiu, X; Redkar, S; Vankayalapati, H; Vollmer, D; Warner, SL; Yoo, CB	1
Banzon, V; Bearss, D; DeSimone, J; Inloes, R; Kanekal, S; Lavelle, D; Phiasivongsva, P; Redkar, S; Saunthararajah, Y; Shi, C; Singh, M; Vaitkus, K	1
Hunewald, OE; Leenen, FA; Molitor, AM; Muller, CP; Schmitz, S; Turner, JD; Vernocchi, S	1
Gattermann, N; Germing, U; Kaivers, J; Kobbe, G; Kündgen, A; Schroeder, T	1

Reviews

1 review(s) available for azacitidine and oligonucleotides

Article	Year
Novel therapies in low- and high-risk myelodysplastic syndrome. Expert review of hematology, 2019, Volume: 12, Issue:10 Topics: Activin Receptors, Type II; Anemia; Antineoplastic Agents; Azacitidine; Bridged Bicyclo Compounds, Heterocyclic; Decitabine; Erythrocyte Transfusion; Hematinics; Humans; Immunoglobulin Fc Fragments; Iron Chelating Agents; Lenalidomide; Myelodysplastic Syndromes; Oligonucleotides; Prognosis; Recombinant Fusion Proteins; Risk Assessment; Stem Cell Transplantation; Sulfonamides; Thalidomide; Thrombopoietin; Transplantation, Homologous	2019

Article

Year

Novel therapies in low- and high-risk myelodysplastic syndrome.

Expert review of hematology, 2019, Volume: 12, Issue:10

Topics: Activin Receptors, Type II; Anemia; Antineoplastic Agents; Azacitidine; Bridged Bicyclo Compounds, Heterocyclic; Decitabine; Erythrocyte Transfusion; Hematinics; Humans; Immunoglobulin Fc Fragments; Iron Chelating Agents; Lenalidomide; Myelodysplastic Syndromes; Oligonucleotides; Prognosis; Recombinant Fusion Proteins; Risk Assessment; Stem Cell Transplantation; Sulfonamides; Thalidomide; Thrombopoietin; Transplantation, Homologous

2019

Other Studies

11 other study(ies) available for azacitidine and oligonucleotides

Article	Year
Induction of endogenous myosin light chain 1 and cardiac alpha-actin expression in L6E9 cells by MyoD1. The Journal of biological chemistry, 1992, Sep-15, Volume: 267, Issue:26 Topics: Actins; Animals; Azacitidine; Base Sequence; Cells, Cultured; Electrophoresis, Agar Gel; Molecular Sequence Data; Muscle Proteins; Myocardium; MyoD Protein; Myosins; Nuclear Proteins; Oligonucleotides; Phosphoproteins; Polymerase Chain Reaction; Rats; RNA, Messenger	1992
The asymmetric methylation of CG palindromic dinucleotides increases sister-chromatid exchanges. Mutation research, 1988, Volume: 197, Issue:1 Topics: Aedes; Animals; Azacitidine; Base Sequence; Cell Cycle; Cell Line; Cricetinae; Cricetulus; Cytosine; Dinucleoside Phosphates; Female; Guanine; Methylation; Oligonucleotides; Ovary; Sister Chromatid Exchange	1988
Methylation of either cytosine in the recognition sequence CGCG inhibits ThaI cleavage of DNA. Nucleic acids research, 1984, Nov-12, Volume: 12, Issue:21 Topics: 5-Methylcytosine; Adenoma; Animals; Azacitidine; Base Sequence; Cell Line; Cytosine; Deoxyribonucleases, Type II Site-Specific; DNA Restriction Enzymes; DNA, Neoplasm; Methylation; Oligodeoxyribonucleotides; Oligonucleotides; Pituitary Neoplasms; Rats; Substrate Specificity	1984
The mechanism of inhibition of DNA (cytosine-5-)-methyltransferases by 5-azacytosine is likely to involve methyl transfer to the inhibitor. The Biochemical journal, 1995, Apr-01, Volume: 307 ( Pt 1) Topics: Azacitidine; Base Sequence; DNA (Cytosine-5-)-Methyltransferases; DNA-Cytosine Methylases; Escherichia coli; Hot Temperature; Methylation; Models, Chemical; Molecular Sequence Data; Oligonucleotides; S-Adenosylmethionine; Sodium Dodecyl Sulfate	1995
Epigenetic silencing of multiple interferon pathway genes after cellular immortalization. Oncogene, 2003, Jun-26, Volume: 22, Issue:26 Topics: Antimetabolites, Antineoplastic; Azacitidine; Cell Division; CpG Islands; Decitabine; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Down-Regulation; Fibroblasts; Gene Silencing; Humans; Interferons; Oligonucleotide Array Sequence Analysis; Oligonucleotides; Phenotype; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; Up-Regulation	2003
Delivery of 5-aza-2'-deoxycytidine to cells using oligodeoxynucleotides. Cancer research, 2007, Jul-01, Volume: 67, Issue:13 Topics: Antineoplastic Agents; Azacitidine; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p16; Decitabine; DNA Methylation; Dose-Response Relationship, Drug; Drug Delivery Systems; Epigenesis, Genetic; Genetic Therapy; Humans; Models, Chemical; Myelodysplastic Syndromes; Oligonucleotides; Triazines; Urinary Bladder Neoplasms	2007
Quantitation of DNA methylation by melt curve analysis. BMC cancer, 2009, Apr-24, Volume: 9 Topics: Algorithms; Antimetabolites, Antineoplastic; Azacitidine; Cell Line, Tumor; Colorectal Neoplasms; Cyclin-Dependent Kinase Inhibitor p16; Decitabine; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; DNA, Neoplasm; Esophageal Neoplasms; Hot Temperature; Humans; Immunohistochemistry; Nucleic Acid Denaturation; Oligonucleotides; Polymerase Chain Reaction; Promoter Regions, Genetic; Tissue Inhibitor of Metalloproteinase-3; Tumor Suppressor Proteins	2009
Induction of apoptosis of non-small cell lung cancer by a methylated oligonucleotide targeting survivin gene. Cancer gene therapy, 2010, Volume: 17, Issue:6 Topics: Apoptosis; Azacitidine; Carcinoma, Non-Small-Cell Lung; Caspase 3; Cell Line, Tumor; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Modification Methylases; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Apoptosis Proteins; Lung Neoplasms; Microtubule-Associated Proteins; Oligonucleotides; Reverse Transcriptase Polymerase Chain Reaction; Survivin; Transfection	2010
S110, a 5-Aza-2'-deoxycytidine-containing dinucleotide, is an effective DNA methylation inhibitor in vivo and can reduce tumor growth. Molecular cancer therapeutics, 2010, Volume: 9, Issue:5 Topics: Animals; Antimetabolites, Antineoplastic; Azacitidine; Cell Line, Tumor; Cell Proliferation; Decitabine; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Down-Regulation; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Models, Biological; Neoplasms; Oligonucleotides; Treatment Outcome; Tumor Burden; Xenograft Model Antitumor Assays	2010
S110, a novel decitabine dinucleotide, increases fetal hemoglobin levels in baboons (P. anubis). Journal of translational medicine, 2010, Oct-08, Volume: 8 Topics: Animals; Azacitidine; DNA Methylation; Fetal Hemoglobin; Oligonucleotides; Papio; Promoter Regions, Genetic	2010
Where does transcription start? 5'-RACE adapted to next-generation sequencing. Nucleic acids research, 2016, Apr-07, Volume: 44, Issue:6 Topics: 5' Untranslated Regions; Azacitidine; Cell Line, Tumor; Dexamethasone; Exons; Genetic Loci; Genetic Variation; High-Throughput Nucleotide Sequencing; Humans; Interferon-gamma; Introns; Nucleic Acid Amplification Techniques; Oligonucleotides; Promoter Regions, Genetic; Protein Isoforms; Receptors, Adrenergic, beta-2; Receptors, Glucocorticoid; RNA Caps; Staining and Labeling; Transcription Initiation Site; Transcription Initiation, Genetic	2016